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Acute massive splenic 
infarction with complete 
liquefaction of the spleen 
in sickle cell disease
To the Editor: The link between 
splenic sequestration and mas-
sive infarction has been noted by 
several authors.1,2 Large splenic in-
farcts have been reported in sickle 
cell trait patients with normal sized 
spleens, an event precipitated by 
hypoxia during high altitude flights 
in an unpressurised aircraft or dur-
ing mountain climbing. Massive 
splenic infarction has also been re-
ported in patients with other sickle 
cell variants, where splenomegaly is 
common mainly in Hb sickle cell 
disease (SCD), in Sβ+ thalassaemia 
and Hb SE disease.3 Many of these 
patients start with splenic seques-
tration syndrome, followed by clini-
cal deterioration leading to splenic 
infarction. In SCD, infarction is 
reportedly induced by stressful con-
ditions including severe generalized 
painful crisis, septicemia, the post-
operative period, strenuous exercise 
and in the postpartum state. It has 
also been reported following high 
altitude travel, including flying in 
modern pressurized aircraft. Hence 
SCD patients with splenomegaly 
are advised against air travel when 
possible, and if deemed unavoidable, 
they are advised to have a pre-travel 
simple or exchange transfusion in 
addition to adequate hydration.
In a study of 134 SCD patients 
who underwent splenectomy in 
Saudi Arabia, only two patients 
(1.49%) had massive splenic infarc-
tion.3 Repeated attacks of vaso-oc-
clusion, which are usually small 
and often asymptomatic leading 
to splenic infarction, often occur 
in children and result in autosple-
nectomy. However a significant 
number of SCD patients in Oman 
(60%) have preserved splenic func-
tion with some splenomegaly, well 
into adulthood, making them liable 
for splenic complications including 
sequestration and infarction.4,5 The 
preserved spleen is due in part at 
least to the high prevalence of both 
alpha-thalassaemia (48%), and beta-
thalassaemia (2.6%) in the country.5 
Similar results in the temporal se-
quence of splenic dysfunction in 
SCD have been reported by others 
in the region.6 While splenic infarc-
tion is a well recognized complica-
tion of SCD, massive splenic infarc-
tion with complete liquefaction of 
the spleen is rarely reported.7  We 
report our experience with three 
patients with SCD who had mas-
sive splenic infarction among a large 
number of patients with SCD who 
had splenectomy (Table 1, 2).
All our patients with splenic 
sequestration had elevated HbF 
at a mean of 7.1% in general and 
22% among the three patients with 
massive infarction. Noticeably, pa-
tients with massive splenic infarc-
tion had a significantly elevated 
HbF (P=.0001, unpaired t test). 
Although elevated HbF is usu-
ally compatible with a milder course 
for SCD, and in association with 
thalassaemia, helps to preserve the 
spleen into adulthood,  high Hb F 
in these patients did not seem to 
protect them from getting splenic 
infarction or sequestration.8 On the 
contrary, this study suggest that a 
significantly elevated HbF may in-
deed be a predictor of high risk for 
massive splenic infarction when the 
spleen is preserved into adulthood, 
and under conditions that may lead 
to tissue hypoxia like stress, infec-
tions, hypoxia, strenuous exercise 
and high altitude. Sickling of eryth-
rocytes occurs in efferent channels 
of the spleen, which sets a chain of 
reactions that progressively involves 
more efferent channels culminating 
in a large splenic infarction. Studies 
of blood flow through the spleen 
done during periods of acute splen-
ic sequestration, verify that blood 
flow is greatly retarded and slug-
gish.7 Therefore, in the presence of 
the above precipitating factors, pa-
tients with SCD who develop acute 
splenic sequestration are at risk of 
Table 1. laboratory test results in sickle cell disease patients, including three patients 
with massive splenic infarction. 
Total, n=79 Hb (g/dL)mean (SD)
WBC 
)×109/L)
mean (SD)
Platelets 
)×109/L)
mean (SD)
Hb F (%)
mean (SD)
Pre-splenectomy 6.4 (1.3) 6.2 (2.5) 156 (57)
Post-splenectomy 9.5 (1.0) 9.3 (2.2) 455 (238)
7.1 (5.2), 
range,  
0.4-19.4
P (paired t test) .001 .001 .001
Massive infarction 
group, (n=3) 
laboratory 
featuresa
  Pre-splenectomy, 
  n=3 7.33 (0.3) 8.8 (1.7) 139.7 (75)
22 (9.3), 
range, 
11.6-29.4
  Post-splenectomy, 
  n=2 11.4 (1.04) 16.8 (5.4) 463 (122)
  P (paired t test) .0137 .093 .099
P value <.05 was considered statistically significant.
aP<.001 for mean Hbf between massice infarction group vs. rest of patients (unpaired t test)
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developing acute splenic infarction, 
and those with a very high HbF and 
large spleen, are at a risk of develop-
ing massive splenic infarction. 
Patients with massive splenic 
infarction usually present with se-
vere left upper quadrant pain, fever 
and pallor. Frequently there is a 
progressive rapid fall in the hemo-
globin level and platelet count.  A 
high index of clinical suspicion is 
necessary to ensure early diagnosis 
and treatment of splenic infarction, 
especially when an SCD patient 
presents with the above symptoms, 
particularly following exposure to a 
stressful situation. This is now fea-
sible by performing a simple ultra-
sound examination of the abdomen. 
Repeated ultrasound examinations 
would also facilitate the followup 
on the progress of this complica-
tion.9  Computerized tomography 
of the abdomen is of utmost help in 
demonstrating the extent of infarcts 
(Figures 1). While splenic infarcts 
due to other causes may appear as 
a wedge-shaped or multiple het-
erogeneous lesion, those in massive 
infarction present as a massive hy-
podense lesion nearly replacing the 
spleen and appear as poorly defined 
areas of low density to a normal ap-
pearing spleen. Furthermore, injec-
tion of a bolus of intravenous con-
trast sharply demarcates the area of 
infarction due to the contrast en-
hancement of the surrounding rim 
of normal tissue making the CT 
scan, one of the most useful modali-
ties for the diagnosis. 
Management of such complica-
tions is challenging to both phy-
sicians and surgeons. One of the 
major concerns is to rule out the 
possibility of a splenic abscess, as 
generally these patients are febrile. 
This could be achieved by perform-
ing an ultrasound-guided aspira-
tion followed by culture of the as-
pirated fluid.  These patients can be 
treated initially with a conservative 
Figure 1. a. Contrast CT scan of patient 1 showing more than 80% splenic infarction, 
b. Contrast CT scan of patient 2 revealing a near complete infarction of the spleen 
enclosed by a rim of splenic tissue, c. radionuclide scan of patient 1 showing very 
minimal splenic function, d. Splenectomy specimen of patient 2 showing a completely 
necrotic cystic spleen.
Table 2. demographic characteristics in massive infarction group (n=3) compared with 
entire study group.
Parameters Case 1 Case 2 Case 3 Study group, n=79
Age (years) 44 30 49
mean age 13 
years, range 
2-49 years
Sex f m m
males, n=43 
(54%) 
m:f;1:1.2
Associated 
features
  fever at 
  presentation Yes Yes Yes
  left upper   
  quandrant pain Yes Yes Yes
  Pleural effusion Yes Yes Yes
  Consolidation       Yes Yes
Spleen size
  dimensions (cm) not measured 20×40×5 17×11×9
mean 
weight, 
594 g, range 
70-2200 g  Weight (g)
not 
measured 2200 705
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approach with appropriate broad 
spectrum antibiotics, and specific 
treatment initiated based on the 
culture report, followed by splenec-
tomy after appropriate vaccinations. 
Since the functional residual splenic 
tissue in massive splenic infarction 
is minimal, splenectomy is not ex-
pected to worsen the hyopsplenic 
state postoperatively. The recom-
mended indications for splenecto-
my in patients with massive splenic 
infarction are persistent upper ab-
dominal pain, pressure symptoms 
of a large spleen, accidental rupture 
and the concern of potential risk of 
infection, or the presence of an ab-
scess of the infarcted splenic tissue. 
Splenectomy could, however, pose 
special technical problems due to 
the size of the spleen and surround-
ing perisplenic inflammation. Dense 
adhesions are usually seen between 
the spleen, diaphragm, stomach 
and perinephric region. This makes 
laparascopic splenctomy a relative 
contraindication.10 Dissection could 
be partly facilitated by decompress-
ing the cystic mass intraoperatively 
by aspiration, while taking precau-
tion to avoid spillage of splenic tis-
sue into the peritoneal cavity, as we 
did in our second case.
In conclusion, massive splenic 
infarction is rare, and constituted 
approximately 3.8% of patients who 
required splenectomy for splenic se-
questration in this large single insti-
tution study. All our three patients 
with massive splenic infarction were 
adults with persistent splenomegaly 
well into adulthood, making them 
liable to this complication. An el-
evated HbF is an important risk 
factor that is significantly associated 
with massive splenic infarction. A 
potential complication of a massive 
infarcted spleen is splenic abscess. 
A high index of clinical suspicion 
supported by radiological evidence 
on ultrasound and CT scan would 
help early, prompt and appropriate 
management. Splenic aspiration 
may be warranted in some of these 
cases. These patients can be man-
aged initially by conservative mea-
sures followed by splenectomy. The 
predominant indication for splenec-
tomy would be persistent pain, pres-
sure effects and the risk of infection 
of the infarcted splenic tissue. 
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Uterine sarcoma: a rare 
cause of uterine inversion
To the Editor: We describe a case 
of uterine inversion associated with 
endometrial sarcoma. Initially, the 
patient was thought to have a cer-
vical mass, as she developed severe 
bleeding and the mass protruded 
outside the vagina. A CT scan was 
done before examination under 
anesthesia, with findings of a large 
uterine mass. We performed a to-
tal abdominal hysterectomy and 
bilateral salpingo-oophorectomy. 
A completely inverted uterus was 
found during surgery. Histology 
showed adenosarcoma of the en-
dometrium. The tumor was limited 
to the endometrium. At the 5-year 
follow up, there was no clinical or 
radiological evidence of recurrent 
disease. Uterine sarcoma should be 
suspected in uterine inversion diag-
nosed in a postmenopausal woman. 
Most cases of uterine inversion are 
obstetric related and encountered 
during the puerperium. Non-puer-
peral uterine inversion is estimated 
to account for just 17% of all cases 
of uterine inversion.1 Benign uter-
ine pathology may present as uter-
ine inversion (submucosal myoma 
is a good example).2 Rarely, uterine 
inversion may complicate the pre-
sentation of uterine sarcoma.6-12 
The differential diagnosis of uter-
ine inversion in a postmenopausal 
woman should include uterine pa-
thology, particularly sarcoma. 
A 76-year-old woman was ad-
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